Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Avinger Inc (NQ: AVGR )

1.480 +0.020 (+1.37%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 114,965
Open 1.460
Bid (Size) 1.460 (10)
Ask (Size) 1.510 (1)
Prev. Close 1.460
Today's Range 1.460 - 1.540
52wk Range 0.1700 - 4.200
Shares Outstanding 5,679,849
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Avinger Expands International Presence with First Commercial Shipment to Chile
REDWOOD CITY, CA / ACCESSWIRE / June 21, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for... 
From Avinger, Inc.
Via AccessWire
Avinger Announces Presentations by Key Opinion Leaders and Live Case Transmission at LINC 2022
REDWOOD CITY, CA / ACCESSWIRE / June 15, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for... 
From Avinger, Inc.
Via AccessWire

Performance

YTD
+190.25%
+190.25%
1 Month
-17.89%
-17.89%
3 Month
-57.71%
-57.71%
6 Month
+190.25%
+190.25%
1 Year
+33.33%
+33.33%

More News

Read More
Avinger Announces Presentations by Key Opinion Leaders at New Cardiovascular Horizons Annual Conference
From Avinger, Inc.
Via AccessWire
Avinger: Q4 Earnings Insights
Via Benzinga
Earnings Preview For Avinger
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Avinger Announces Key Opinion Leader Presentation and Live Case at Vascular Conferences in Germany
From Avinger, Inc.
Via AccessWire
Recap: Avinger Q1 Earnings
Via Benzinga
Avinger Reports First Quarter 2022 Results
From Avinger, Inc.
Via AccessWire
Exposures COVID-19 Product Safety
99 Biggest Movers From Yesterday
Via Benzinga
52 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Avinger to Announce First Quarter 2022 Results on May 10
From Avinger, Inc.
Via AccessWire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Avinger Announces Full Commercial Launch of Lightbox 3
From Avinger, Inc.
Via AccessWire
Avinger Announces Issuance of Three New U.S. Patents in March 2022
From Avinger, Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
Avinger Regains Compliance with Nasdaq Listing Requirements
From Avinger, Inc.
Via AccessWire
Avinger's Return On Capital Employed Overview
Via Benzinga
Avinger Registers 12% Decline In Q4 Revenue, Says Hospital Constraints Impacted Q4
Via Benzinga
Avinger Reports Fourth Quarter and Year End 2021 Results
From Avinger, Inc.
Via AccessWire
Earnings Scheduled For March 22, 2022
Via Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
68 Biggest Movers From Yesterday
Via Benzinga
Avinger to Announce Full-Year 2021 Results on March 22
From Avinger, Inc.
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.